Seeing Is Believing
Currently out of the existing stock ratings of Simos Simeonidis, 33 are a BUY (58.93%), 21 are a HOLD (37.5%), 2 are a SELL (3.57%).
Analyst Simos Simeonidis works with a stock forecast success ratio of 66.9% fulfilled within 476.2 days on average. Previously, Simos Simeonidis worked at RBC.
Simos Simeonidis’s has documented 87 price targets and ratings displayed on 10 stocks. The coverage was on the Healthcare sector.
Most recent stock forecast was given on PBYI, Puma Biotechnology at 06-Jun-2017.
Analyst best performing recommendations are on DVAX (DYNAVAX TECHNOLOGIES).
The best stock recommendation documented was for DVAX (DYNAVAX TECHNOLOGIES) at 4/27/2016. The price target of $17 was fulfilled within 2 days with a profit of $1.53 (8.26%) receiving and performance score of 41.28.
Average potential price target upside
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
205
$22.5 (12.33%)
2 years 11 months 22 days ago
3/5 (60%)
$35.09 (20.65%)
938
Hold
173
$-9.5 (-5.21%)
156
2 years 11 months 24 days ago
14/24 (58.33%)
$2.73 (1.60%)
682
Hold
190
$7.5 (4.11%)
194
3 years 2 months 23 days ago
9/11 (81.82%)
$34.41 (22.12%)
350
Hold
166
$-16.5 (-9.04%)
175
3 years 2 months 23 days ago
23/23 (100%)
$10.41 (6.69%)
828
Buy
155
3 years 3 months 20 days ago
7/7 (100%)
$36.79 (31.12%)
395
What Year was the first public recommendation made by Simos Simeonidis?